Walgreens Boots Alliance (WBA) unveiled a definitive agreement late Thursday to be acquired by an entity affiliated with Sycamore Partners for up to $23.7 billion.
The price tag is based on a cash consideration of $11.45 per share and up to $3 per divested-asset-proceed right, plus net debt, capital leases, present value of opioid liability, and a settlement, Walgreens said. Walgreens will become a private entity and its shares will crease to trade on Nasdaq upon deal close.
The cash consideration represents a 29% premium, and the total consideration represents a premium of up to 63% to Walgreens closing share price of $8.85 as of Dec. 9, the day before media reported the deal.
The transaction has been approved by Walgreens' board and is expected to close in Q4, subject to certain approvals and customary conditions.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。